💊 Fármacos A-Z 🧬 Dianas 🛠 Herramientas 📚 Guías
Todos los fármacos Clases de fármacos Áreas terapéuticas Efectos Secundarios
Guías Glosario Línea de tiempo
Comparaciones Recorridos de fármacos Familias farmacológicas
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Neomycin Sulfate

CHEMBL3989769 Phase 4 Aprobado Unknown
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
712.7 g/mol
LogP
—
Phase
4

This is the sulfate salt form of neomycin used for the same topical and pre-surgical bowel preparation indications.

Peso molecular

712,7000 g/mol

TPSA

436,00 Ų

Áreas terapéuticas

Anestesiología Artritis reumatoide Asma Cáncer colorrectal Cáncer de mama Cáncer de ovario Cáncer de páncreas Cáncer de próstata Cáncer de pulmón de células no pequeñas Cáncer de tiroides Cáncer de vejiga Degeneración macular relacionada con la edad Dermatitis atópica Dermatología Diabetes tipo 2 Dolor crónico Endocrinología Endometriosis Enfermedad cardiovascular Enfermedad de Alzheimer Enfermedad del hígado graso no alcohólico Enfermedad de Parkinson Enfermedad infecciosa Enfermedad inflamatoria intestinal Enfermedad por reflujo gastroesofágico Enfermedad pulmonar obstructiva crónica Enfermedad renal crónica Enfermedad respiratoria Epilepsia Esclerosis múltiple Esquizofrenia Fibrilación auricular Gastroenterología Glaucoma Gota Hematología Hepatitis C Hepatología Hiperlipidemia Hiperplasia prostática benigna Hipertensión Ictus Inmunología Insomnio Insuficiencia cardíaca Leucemia Linfoma Lupus eritematoso sistémico Malaria Manejo del dolor Medicina de trasplantes Melanoma Migraña Nefrología Neurología Obesidad Obstetricia y ginecología Oftalmología Oncología Osteoporosis Psiquiatría Psoriasis Reumatología Trastorno bipolar Trastorno de ansiedad generalizada Trastorno depresivo mayor Trombosis venosa profunda / Embolia pulmonar Tuberculosis Urología VIH/sida

Mecanismo de acción

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

SMILES

C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)CN)O)O)N)O)O)N.OS(=O)(=O)O

InChI

InChI=1S/C23H46N6O13.H2O4S/c24-2-7-13(32)15(34)10(28)21(37-7)40-18-6(27)1-5(26)12(31)20(18)42-23-17(36)19(9(4-30)39-23)41-22-11(29)16(35)14(33)8(3-25)38-22;1-5(2,3)4/h5-23,30-36H,1-4,24-29H2;(H2,1,2,3,4)/t5-,6+,7-,8+,9-,10-,11-,12+,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23+;/m1./s1

Molecular Formula

C23H48N6O17S

HBD / HBA

15 / 23

Enlaces Rotables

9

Átomos Pesados

47

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

This is the sulfate salt form of neomycin used for the same topical and pre-surgical bowel preparation indications.

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Yes, Neomycin Sulfate is an approved drug. It has reached clinical phase 4. It is classified as a Unknown.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3989769. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 197162. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.